Mezzion Pharma Co (XKRX:140410) 3-Year EBITDA Growth Rate : 4.10% (As of Dec. 2023)

View and export this data going back to 2012. Start your Free Trial

What is Mezzion Pharma Co 3-Year EBITDA Growth Rate?

Mezzion Pharma Co's EBITDA per Share for the three months ended in Dec. 2023 was ₩-184.41.

During the past 3 years, the average EBITDA Per Share Growth Rate was 4.10% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 6.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Mezzion Pharma Co was 59.80% per year. The lowest was -52.60% per year. And the median was -16.80% per year.

Competitive Comparison of Mezzion Pharma Co's 3-Year EBITDA Growth Rate

For the Drug Manufacturers - General subindustry, Mezzion Pharma Co's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Mezzion Pharma Co's 3-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Mezzion Pharma Co's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Mezzion Pharma Co's 3-Year EBITDA Growth Rate falls into.

Mezzion Pharma Co 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Mezzion Pharma Co (XKRX:140410) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Mezzion Pharma Co 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Mezzion Pharma Co's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Mezzion Pharma Co (XKRX:140410) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mezzion Pharma Co (XKRX:140410) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

C&H, Samseong-dong, 154-8, Gangnam-gu, Dongdaemun-gu, Seoul, KOR, 135-879

Website

http://www.mezzion.co.kr

Mezzion Pharma Co is a South Korea based drug manufacturer company. It develops and manufactures pharmaceutical products for erectile dysfunction and benign prostatic hyperplasia.

Mezzion Pharma Co (XKRX:140410) Headlines

No Headlines